OTHER NAMES: Nil
USE: A bait for ants
UN NUMBER: n/a
HAZCHEM CODE: n/a
DANGEROUS GOODS CLASS: n/a
POISONS SCHEDULE: 5
PHYSICAL DESCRIPTION/PROPERTIES
APPEARANCE: A honey colored gel.
FLASHPOINT (0C): n/a
BOILING POINT (0C): n/a
FLAMMABILITY LIMITS (%): n/a
VAPOUR PRESSURE (___): n/a
SOLUBILITY IN WATER (g/L): Partially soluble in water with suspended and settled
ingredients.
SPECIFIC GRAVITY: 1 g/mL
INGREDIENTS
CHEMICAL ENTITY |
CAS NO |
PROPORTION |
Boric Acid |
10043-35-3 |
5% |
Inert and Non Hazardous Compounds |
|
95% |
HEALTH HAZARD INFORMATION
______________________________________________________
HEALTH EFFECTS
ACUTE:
SWALLOWED: Boric Acid has a relatively low acute toxicity. Small amounts would
normally not cause any adverse effects if swallowed. Larger amounts may cause
gastrointestinal symptoms.
EYES:
Not an irritant. May cause reversible conjunctivitis.
SKIN: Not an irritant. No evidence of tissue damage. May cause slight irritation
on damaged skin. Boric Acid is not absorbed through intact skin.
INHALED: Product can not be inhaled due to paste formulation..
CHRONIC: A technical report issued by the National Toxicology Program
(USA) showed no evidence of carcinogenicity from a 2 year bioassay on Boric Acid in mice
fed doses of 2500 to 5000 ppm in the diet. No mutagenic activity was observed for Boric
Acid in four short term mutagenicity assays.
FIRST AID
SWALLOWED: If poisoning occurs contact a doctor or poisons information
center.
If swallowed, and if more than 15 minutes from a hospital induce vomiting preferably using
Ipecac Syrup AFP.
EYES: If in eyes hold eyelids open, flood with water for at least 15 minutes. If
irritation persists see a doctor.
SKIN: No effect expected on intact skin. If skin is damaged wash with soap and
water. If irritation persists see a doctor.
INHALED: Not a hazard due to paste formulation.
ADVISE TO DOCTOR: Observation only is required for adult ingestion
of <6 grams of Boric Acid. For ingestion in excess of 6 grams, maintain adequate kidney
function and force fluids. Gastric lavage is recommended for symptomatic patients only.
Haemodialysis should be reserved for massive acute ingestion or patients with renal
failure. Boric Acid analysis of urine or blood are only useful for documenting exposure
and should not be used to evaluate severity of poisoning or to guide treatment.
_____________________________________________________
PRECAUTIONS FOR USE
_____________________________________________________
EXPOSURE STANDARDS: No occupational exposure standards have been
set for this product. Inhalation should not be a risk under normal use.
ENGINEERING CONTROLS: No engineering controls required.
PERSONAL PROTECTION: The ready to use syringes prevent risks of
exposure under normal use conditions. Wear safety glasses if the method of use poses a
risk of eye contamination.
FLAMMABILITY Product is not flammable. Boric Acid has some flame
retardant properties.
______________________________________________________
SAFE HANDLING INFORMATION
_____________________________________________________
STORAGE AND TRANSPORT: Store in a cool dry place in sealed
original containers away from direct sunlight. Store away from food, feed or any items
intended for human or animal consumption. Keep out of reach of children. Product is not
classified as a dangerous good under current transport regulations .
SPILLS AND DISPOSAL: Spills should be wiped up with a damp rag
while still wet and disposed of in the rubbish bin. Wrap any rags or product in newspaper
before disposal. Large spills should be disposed of at a landfill site.
FIRE/EXPLOSION HAZARD: No unusual fire or explosion hazards exists.
Boric Acid reacts as a weak acid and may cause the corrosion of weak metals. Reaction with
strong reducing agents such as metal hydrides or alkali metals may generate hydrogen and
hence present an explosion hazard.
OTHER INFORMATION
LD50 Oral (Ingestion) - rat 3500-4100 mg/kg
LD50 Dermal (Skin Contact) - rabbits >2000 mg/kg
This data refers to the active constituent.
The toxicity of the product is greater after repeat exposures than in a single dose.
Animal studies show no signs of carcinogenic or teratogenic effects.
_____________________________________________________
NOTICE: Information for this product is believed to be
reliable, however buyer and user assume all risk of use, handling and storage whether in
accordance with directions or not. Barmac Industries Pty Ltd and its agents give no
guarantee or warranty of any kind express or implied concerning the use of this product
and will not accept any responsibility whatsoever whether in contract or tort for any loss
including consequential loss arising out of the use of this product or caused by this
product.
